Grant: Engage Grants Program
University of Waterloo
$25,000.00
Bio-compatible coating of nano-filters for medical applications
EF 2015-16
Résumé
Qidni Labs Inc. is developing Qidni-X1, which is an implantable renal replacement therapy for three million patients with End Stage Renal Disease (ESRD). The core technology behind Qidni-X1 is an implantable nano-filtration system. This system comprises nano-filters for filtration of uremic toxins and water from blood.
The problem that the company is facing is how to coat their nano-filters with pyrolytic carbon. This project will focus on developing the best coating.
Programme
Engage Grants Program
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
491460-2015
Name nom
Kleinke, Holger
Department département
Chemistry
Organization id
33
Institution établissement
University of Waterloo
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2015
Competition year année de concours
2015
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
2006
Research subject group en
Materials science and technology
Research subject group fr
Science et technologie des matériaux
Research subject en
Biomaterials
Research subject fr
Biomatériaux
Partie
1
Nb partie
1
Application title
Bio-compatible coating of nano-filters for medical applications
Keyword
NSERC
Application summary
Qidni Labs Inc. is developing Qidni-X1, which is an implantable renal replacement therapy for three million patients with End Stage Renal Disease (ESRD). The core technology behind Qidni-X1 is an implantable nano-filtration system. This system comprises nano-filters for filtration of uremic toxins and water from blood.
The problem that the company is facing is how to coat their nano-filters with pyrolytic carbon. This project will focus on developing the best coating.